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Abstract
Background: The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of
cefuroxime at cord clamp for prevention of post-cesarean infectious morbidity has not been assessed.
Methods: Women scheduled for cesarean delivery were randomized to receive a single dose of either 3 g of
ampicillin-sulbactam or 1.5 g of cefuroxime intravenously, after umbilical cord clamping. An evaluation for
development of postoperative infections and risk factor analysis was performed.
Results: One hundred and seventy-six patients (median age 28 yrs, IQR: 24-32) were enrolled in the study during
the period July 2004 - July 2005. Eighty-five (48.3%) received cefuroxime prophylaxis and 91 (51.7%) ampicillin/
sulbactam. Postoperative infection developed in 5 of 86 (5.9%) patients that received cefuroxime compared to 8 of
91 (8.8%) patients that received ampicillin/sulbactam (p = 0.6). In univariate analyses 6 or more vaginal
examinations prior to the operation (p = 0.004), membrane rupture for more than 6 hours (p = 0.08) and blood
loss greater than 500 ml (p = 0.018) were associated with developing a postoperative surgical site infection (SSI). In
logistic regression having 6 or more vaginal examinations was the most significant risk factor for a postoperative
SSI (OR 6.8, 95% CI: 1.4-33.4, p = 0.019). Regular prenatal follow-up was associated with a protective effect (OR 0.04,
95% CI: 0.005-0.36, p = 0.004).
Conclusions: Ampicillin/sulbactam was as safe and effective as cefuroxime when administered for the prevention
of infections following cesarean delivery.
Trial registration: Clinicaltrials.gov identifier: NCT01138852
Background
The majority of obstetrical interventions involves some
degree of bacterial contamination. Thus they are classi-
fied as “clean-contaminated” even when the patient has
no preoperative symptoms of active infection [1]. Cesar-
ean delivery is considered a clean-contaminated proce-
dure when scheduled cesarean delivery without labor
and/or ruptured membranes occurs and, contaminated
when emergency cesarean delivery with labor and/or rup-
tured membranes occurs. Several studies have shown the
beneficial effect of peri-operative antimicrobial prophy-
laxis in preventing post-surgical infection after cesarean
d e l i v e r y[ 2 ] .S i n g l ed o s ep r o p h y l a x i sa p p e a r st ob ea n
excellent regimen compared to multiple day regimens
independent of urgency of procedure [2-6]. Most surgical
- site infections (SSI) after cesarean delivery, are soft
tissue infections caused by organisms originating in the
lower genital tract such as gram negative microorganisms
and anaerobes [7-9]. Some authors argue that the most
effective regimen has not been established yet [10]. For
example single dose cephalosporins have been widely
used for antimicrobial prophylaxis during cesarean deliv-
ery [11-13]. However in one study it was shown that a
broader combination of cefazolin and metronidazole
provided better efficacy with regards to post-operative
infectious diseases morbidity and duration of hospitaliza-
tion when compared with cefazolin alone [10]. The anti-
microbial combination of ampicillin-sulbactam has
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second generation cephalosporins [14]. This activity
includes enterococci and anaerobes and in a recent ran-
domized trial it was shown to be superior than cehalos-
porins in perioperative chemoprophylaxis in biliary
surgery [15]. Moreover, in an obstetrical study it fared
better than ampicillin alone in preventing post-cesarean
infection in women that had ruptured membranes [16].
In the current study, the main goal was to evaluate the
efficacy and safety of a single dose of ampicillin/sulbac-
tam compared to a single dose of cefuroxime at cord
clamp for prevention of post-cesarean infectious mor-
bidity. The main hypothesis was that ampicillin-sulbac-
tam will result in fewer post-cesarean infections.
Methods
The investigation was designed to evaluate the efficacy
and safety of a single dose of ampicillin/sulbactam 3 g
compared to a single dose of cefuroxime 1.5 g in pre-
venting postoperative morbidity. The primary outcome
was development of an infection either at the surgical
site or elsewhere e.g. urinary tract infection. A prospec-
tive randomized controlled study was performed from
July 2004 to December 2008 in one major tertiary care
hospital, Nikaia’s Regional General Hospital “Agios Pan-
teleimon”, in Athens Greece. All patients undergoing a
cesarean delivery were eligible. Using a random-number
generator (STATS version 1.1, 1998 program; Decision-
Analyst Inc, Arlington, Tex), patients were randomly
assigned to receive either 1.5 g of cefuroxime, or 3 g of
ampicillin/sulbactam intravenously after the time the
umbilical cord was clamped. The generation of the allo-
cation sequence, the enrollment and the assignment of
participants to their groups was performed by a physi-
cian dedicated to the study. The sequence was obtained
using a central telephone number and it was concealed
until interventions were assigned. Participants were
enrolled sequentially and were blinded to the interven-
tion, however the physician administering the interven-
tion and assessing the outcomes was not. Patients with
known hypersensivity to penicillin, cephalosporins, those
who required concomitant antibiotic therapy or had
received antibiotics during the 72 hours immediately
preceding their enrollment, were excluded. Prior to the
enrollment in the study, the medical history was taken
and a physical examination was performed. Then the
procedure was explained and discussed with each
patient and written informed consent was obtained
when a decision to proceed to a cesarean delivery was
made. Preoperative vital signs including blood pressure,
pulse rate, and temperature were also recorded. Blood
samples were taken for complete blood counts with dif-
ferential and blood chemistries. Concerning patients
with diabetes mellitus, glycemic control was established
preoperatively by close monitoring and insulin drips, if
appropriate. Data on parity, indication of cesarean deliv-
ery, number of vaginal examinations, premature rup-
tures of membranes, duration of surgery, blood loss,
type of anesthesia, BMI and American Society of
Anesthesiologists (ASA) score were carefully recorded.
The patients were under weekly clinical and laboratory
postoperative monitoring for infection development dur-
ing a 30- day period. All of them were reminded of the
appointment via telephone, and a structured clinical
protocol was used. The following information was
recorded daily during the postoperative hospitalization
a n dt h ef o l l o w - u pp e r i o d :t h ep a t i e n t ’sv i t a ls i g n s ,c l i n i -
cal signs and symptoms of wound infection (such as
induration, heat, erythema, pain and drainage from the
wound), and signs and symptoms of infections of other
sites. Postoperative superficial or deep incision soft tis-
sue SSI and intraabdominal abscess were defined
according to published criteria [1]. Endometritis was
defined as the presence of fever (38°C or higher) in
association with one or more of the following: uterine
tenderness, foul smelling lochia, and leucocytosis of
>12.000 after exclusion other site of infection that devel-
oped within the first 5 days after the delivery [17]. Clini-
cal sense and caution was exercised not to include
normal leukocytosis that can be seen during pregnancy
and immediately post-partum. Endometritis qualified
also as organ SSI. Presence of fluid collection with local
signs of inflammation with or without fever, with or
without leukocytosis, and with negative culture results
was defined as a sterile wound collection. Specimens for
both aerobic and anaerobic bacteriologic culture were
obtained in case of a postoperative infection and from
all wounds. The prophylaxis was considered to have
failed if a postoperative infection occurred. Mothers
whose postpartum fever was clearly associated with
other known causes such as deep vein thrombosis were
excluded. The study was conducted in accordance with
the Declaration of Helsinki, was approved by the institu-
tional scientific review board and the ethics committee
of the Nikaia’s Regional General Hospital “Agios Pante-
leimon"and all patients participating in the study signed
an informed written consent. The study was registered
in the National Institutes of Health clinical trials registry
(Clinicaltrials.gov identifier: NCT01138852).
Statistical analysis
Data are reported as mean (SD), rates or odds ratio (OR)
with 95% confidence interval. We used a paired-sample
tt e s tf o rn o r m a l l yd i s t r i b u t e dd a t aa n daW i l c o x o n
signed rank test otherwise. Baseline characteristics were
compared between the two groups for each of the study
medication using non-parametric, independent-sample
tests (Kruskal-Wallis and Wilcoxon rank) for continuous
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The drug efficacy was accessed by development of an
infection either at the surgical site or elsewhere e.g. urin-
ary tract infection. The association between known risk
factors for infection e.g. comorbidities, ASA score, obe-
sity (Body Mass Index ≥ 25 kg/m
2, type (elective vs. non
- elective) and duration of operation, blood loss, presence
of bacterial vaginosis, preoperative vaginal examinations
(also dichotomized as 6 or more), premature rupture of
membranes (also dichotomized as 6 hours or more) and
the development of any postoperative infection or SSI
was examined by univariate analysis. Backward stepwise
logistic regression analysis was then conducted to deter-
mine independent correlates of post-operative infection
or SSI. Variables with P ≤ 0.10 in the univariate analysis
were considered for inclusion in the multivariate analysis.
Significance was set at p < 0.05. It was estimated accord-
ing to published literature [2] that for an expected reduc-
tion of post-surgical infection between patients not
exposed and exposed to ampicillin-sulbactam from
approximately 15% [2] to 1.5%, a power of 80%, and a
two-tailed alpha of 0.05, 78 patients would be required
for each arm of the study. All statistical tests used were
two-sided. SPSS version 10.0 for Windows software
(SPSS, Inc., Chicago, IL) was used for data analysis.
Results
A flow diagram of the study according to the Consort
statement is depicted in Figure 1. In total 188 patients
were assessed for eligibility and 176 were included in
the study from July 2004 to July 2005. The only reason
for exclusion was reported allergy to beta-lactam anti-
biotics. The main characteristics of the patients who
participated in the study with respect to the prophylaxis
group are presented in tables 1 and 2. Among the 176
patients [median age 28 yrs old (IQR: 24-32)] complet-
ing the study, 85 (48.3%) received cefuroxime and 91
(51.7%) ampicillin/sulbactam. There were no statistically
significant differences in outcome parameters between
the two treatment groups. Postoperative infections
d e v e l o p e di n1 3( 7 . 4 % )p a t i e n t s ;f i v eo u to f8 5( 5 . 9 % )
patients that received cefuroxime and 8 out of 91 (8.8%)
patients that received ampicillin-sulbactam (p = 0.6).
More specifically 10 cases (5.7) of postoperative SSI
developed (Figure 2), 6 in the ampicillin/sulbactam
group and 4 in the cefuroxime group (p = 0.7). Five
qualified as superficial incisional SSIs and 5 as organ/
space SSIs (4 cases of post-partum endometritis and one
of intrabdominal collection). Two SSIs were associated
with a positive wound culture for Staphylococcus aureus,
one with Stapylococcus epidermidis (deep infection with
intra-abdominal collection), one with Proteus mirabilis,
one with Enterobacter aerogenes and one with Entero-
coccus faecalis. The superficial incisional SSI that was
attributed to Enterococcus spp developed in a patient
that received prophylaxis with cefuroxime. Four cases of
endometritis were observed, 2 in each group. All cases
of endometritis were associated with the isolation of
Gram negative aerobic bacteria [2 cases with E. coli (one
had a concomitant urinary tract infection with the same
pathogen) and one case each where Citrobacter spp and
Enterobacter cloacae were isolated respectively]. Finally,
another urinary tract infection developed and E. coli was
cultured again. All pathogens except for the enterococ-
cal species were susceptible to the 2 prophylaxis regi-
mens used. No significant differences in risk factors for
infection were identified between the two groups.
Variables that were associated with any infection or SSI
during univariate analysis are shown in table 2. For SSI
univariate analysis disclosed as important risk factors,
ruptured membranes (OR 3.7, 95% CI: 0.99-13.7, p =
0.07), 6 or more vaginal examinations prior to the cesar-
ean (OR 8.2, 95% CI: 2.2-31.2, p = 0.004), emergency
cesarean (OR 4.4, 95% CI: 0.91-21.4, p = 0.056), and
blood loss greater than 500 ml (OR 6.1, 95% CI: 1.2-29.4,
p = 0.018). Regular prenatal follow-up (OR 0.13, 95% CI:
0.02-0.75, p = 0.05) and the performance of general
anesthesia appeared to be protective (OR 0.13, 95% CI:
0.03-0.65, p = 0.06). For SSI multivariate analysis dis-
closed six or more vaginal examinations performed prior
to the cesarean delivery as the most significant risk factor
for a postoperative SSI (OR 6.8, 95% CI: 1.4-33.4, p =
0.019) and regular prenatal follow-up to be associated
with a protective effect (OR 0.04, 95% CI: 0.005-0.36, p =
0.004). Regional anesthesia approached but did not reach
statistical significance for an SSI development (OR 5.6,
95% CI: 0.9-36, p = 0.07). For development of any infec-
tion similar results to the SSI ones were obtained in uni-
variate and multivariate analysis. In multivariate analyses
having six or more vaginal examinations performed prior
to the cesarean delivery was the most significant risk fac-
tor for any postoperative infection (OR 6.9, 95% CI: 1.8-
26.1, p = 0.005) whereas regular prenatal follow-up was
associated with a protective effect (OR 0.09, 95% CI:
0.01-0.6, p = 0.01). In the same analysis blood loss of
greater than 500 ml approached but did not reach signifi-
cance (OR 3.6, 95% CI: 0.9-15, p = 0.077).
Finally, patients that developed an infection had a
lengthier hospital stay [median of 5 (IQR: 4 - 8) vs. 4
days (IQR: 4 - 4), Mann - Whitney, p < 0.001). All
patients with an infection responded well to subsequent
antibiotics. No adverse drug reactions were reported.
Discussion
In this randomized trial, we report the efficacy of a single
peri-operative dose of ampicillin-sulbactam or cefurox-
ime as chemoprophylaxis in patients undergoing cesarean
delivery. Both cefuroxime and ampicillin-sulbactam
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overall and SSI in specific. Both regimens were well toler-
ated and no side-effects were noted. The most significant
risk factors for postoperative infection were 6 or more
vaginal exams prior to the cesarean, blood loss of greater
than 500 ml during the operation and inadequate prena-
tal follow-up. Patients with SSI had a lengthier hospital
stay but all did well during follow-up.
Cephalosporins have been widely used as prophylaxis
in obstetrics and gynecological surgery. However they
are not active against Enterococcus spp [18]. Ampicillin-
sulbactam has a wider antimicrobial spectrum than
cephalosporins that includes enterococci. The use of a
single dose of ampicillin/sulbactam as a prophylactic
agent to prevent infection following cesarean delivery in
both non-select and selct populations has been reported
in the past [16,19,20]. One study has looked at the com-
parison between ampicillin-sulbactam and cefotetan (a
cephalosporin with anaerobic activity frequently used in
obstetrics and gynecology) in 170 patients and did not
identified significant differences in rates of postoperative
endometritis and urinary tract infections [19]. To the
best of our knowledge no direct comparison of ampicil-
lin-sulbactam and cefuroxime has been performed to
date regarding their use as chemoprophylaxis. We
elected to compare the two regimens assuming a benefit
for the agent with the wider spectrum. In support of
our hypothesis, enterococci are among the most fre-
quent pathogens implicated in cases of post-partum
emdometritis after cephalosporin prophylaxis [21-23].
Moreover a comparison of chemoprophylaxis with
ampicillin-sulbactam versus ampicillin alone has been
previously reported [16] and the combination fared bet-
ter than the single agent in the group of women with
ruptured membranes [16]. However, our study did not
establish any superiority for the ampicillin-sulbactam
regimen over cefuroxime. The likely reason is that we
only observed one enterococcal post-operative infection
out of 13 (for a rate of 7.7%) and no anaerobic infec-
tions. Based on calculation derived from our study fig-
ures, if all our patients weret od e v e l o pas u s c e p t i b l e
enterococcal post-operative infection we would have
needed 34 patients developing such an infection to see 1
case of enterococcal infection prevented. Nevertheless
other factors may be operative as well such as character-
istics of the populations examined. The presented study
highlights the importance of the appropriate use of a
simple peri-operative prophylaxis regimen in patients
undergoing cesarean section. The alternative regimen
i.e. ampicillin-sulbactam presented in this report was
associated with essentially negligible drug related toxi-
city and in addition it may be associated with reduced
selection of pathogens resistant to cephalosporins such
as enterococci. The one enterococcal SSI was noted in
Assessed for eligibility 
N= 188 
Randomized 
N= 176 
Excluded 
N= 12 
Allocated to group A 
N= 85 (48.3%) 
Allocated to group B 
N=91(51.7%) 
Follow-up for 30 days 
N=85 
Follow-up for 30days 
N=91 
Analyzed 
N=91 
Analyzed 
N=85 
Not meeting inclusion criteria 
N=12 
Refused to participate 
N=0 
Figure 1 Flow diagram of the study according to the Consort statement.
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occurrence of infection due to a resistant pathogen in
our ampicillin-sulbactam treated group. On the other
hand a wider spectrum antimicrobial such as ampicillin-
sulbactam was not superior to a more narrow spectrum
cephalosporin. In accordance a meta-analysis showed
similar efficacy between ampicillin (alone without the
combination with sulbactam) and first or second or
even third generation cephalosporins in the prevention
of endometritis [24]. More research is necessary as
newer reports suggest that the use of extended-spectrum
regimens (involving azithromycin or metronidazole)
after cord clamp may reduce post-cesarean maternal
infection by up to 50% [25]. Nevertheless the authors
believe that simple narrow spectrum antimicrobials
should continue to be used for perioperative prophylaxis
(especially in low-risk patients) and should be integrated
in an appropriate antimicrobial stewardship program
There does not appear to be added benefit in utilizing a
more broad spectrum and the authors believe that
simple narrow spectrum antimicrobials (especially in
low risk subjects) should continue to be used for
perioperative prophylaxis and should be integrated in an
appropriate antimicrobial stewardship program. On the
other hand prophylaxis regimens should assist in redu-
cing health care costs without an adverse effect in the
quality of the care provided to the patient. The ampicil-
lin-sulbactam regimen used in our study costs 5,07
Euros per patient in our country and was more costly
than the cefuroxime regimen that costs 2,38 Euros per
patient.
The current study confirms the well accepted beneficial
role of antimicrobial prophylaxis for any woman under-
going elective or emergency cesarean delivery regardless of
the presence or absence of specific risk factors. The opera-
tion is known to carry a 5- to 20-fold greater risk of infec-
tion than normal vaginal delivery [9,26]. The potential
bacterial pathogens may contaminate the endometrial cav-
ity at the time of cesarean delivery. During a cesarean
delivery, the uterine incision, pelvic peritoneum and
abdominal wound can become contaminated. Endometri-
tis which is the most common infectious complication
after delivery, is more frequent and severe after cesarean
delivery [27,28]. Wound infection occurs in a large
Table 1 Demographics and other characteristics of the population studied
Variable Total group
n = 176
Cefuroxime
n = 85 (48.3%)
Ampicillin/Sulbactam
n = 91 (51.7%)
P - value
Age, median (IQR) 28 (24-32) 27 (23.5-31) 28 (24-32) 0.7
Multiparity, n (%) 98 (55.7) 48 (56.5) 50 (54.9) 0.9
BMI ≤24 kg/m
2, n (%) 39 (22.2) 18 (21.2) 21 (23.1) 0.9
BMI ≥ 30 kg/m
2, n (%) 76 (43.2) 38 (44.7) 38 (41.8) 0.8
Diabetes mellitus, n (%) 7 (4) 3 (3.5) 4 (4.4) 1
Hypertension (including pre-eclampsia)/other cardiovascular condition, n (%) 36 (20.5) 16 (18.8) 20 (22) 0.7
Chronic respiratory disease, n (%) 1 (0.6) 1 (1.2) 0 (0) 0.5
Corticosteroid use, n (%) 2 (1.1) 2 (2.4) 0 (0) 0.2
Creatinine in mg/dL, median (IQR) 0.6 (0.5-0.7) 0.6 (0.5-0.7) 0.6 (0.5-0.7) 0.6
ASA ≥ 2, n (%) 59 (33.5) 27 (31.8) 32 (35.2) 0.7
Regular prenatal f/u, n (%) 167 (94.9) 83 (97.6) 84 (94.4) 0.4
Vaginal examinations, n (%) 96 (54.5) 45 (52.9) 51 (56) 0.8
Vaginal examinations ≥ 6, n (%) 23 (13.1) 11 (12.9) 12 (13.2) 1
Ruptured membranes, n (%) 54 (30.7) 24 (28.2) 30 (33) 0.5
Ruptured membranes ≥ 6 hours, n (%) 9 (5.1) 3 (3.5) 6 (6.6) 0.5
Non-elective emergency cesarean, n (%) 87 (49.4) 42 (49.4) 45 (49.5) 1
General anesthesia 110 (62.5) 50 (58.8) 60 (65.9) 0.4
Duration of surgery >60 minutes, n (%) 111 (63.1) 53 (62.4) 58 (63.7) 0.9
Blood loss >500 ml, n (%) 74 (42) 37 (43.5) 37 (40.7) 0.8
All post-op infections, n (%) 13 (7.4) 5 (5.9) 8 (8.8) 0.6
Post-cesarean endometritis, n (%) 4 (2.3) 2 (2.4) 2 (2.2) 1
Post-cesarean SSI (includes endometritis), n (%) 10 (5.7) 4 (4.7) 6 (6.6) 0.7
Duration of hospitalization in days, median (IQR) 4 (4-4) 4 (4-5) 4 (4-4) 0.09
Duration of hospitalization post-operatively in days, median (IQR) 2 (2-2) 2 (2-2) 2 (2-2) 0.04
BMI: Body mass index, ASA: American society of Anesthesiologists score, Post-op: postoperative, IQR: Interquartile range
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out antibacterial prophylaxis [9,29]. Since the early studies
[30] extensive research has examined the role of antimi-
crobial prophylaxis in preventing post-operative infections
and especially endometritis. The benefit of prophylaxis is
most clearly seen in those at increased risk for infection,
for example, those in active labors and with ruptured
membranes [3,26]. In a recent report, the risk of SSI
increased 2.58 fold (95%CI, 1.3-5.1) in the absence of pro-
phylaxis in a population of 765 women [29]. In a large
meta-analysis it was shown that the use of antibiotic pro-
phylaxis led to a reduction of up to 75% of cases of post-
cesarean delivery endometritis and a decrease in wound
infections [2]. This observation was independent of
whether an elective or non-elective procedure was per-
formed and independent of the antimicrobial regimen
used [2]. The relative risk of endometritis reduction for
the 11,937 patients analyzed was 0.39 (95% CI 0.31 to
0.43) [2]. Accordingly our study showed a rate of 7.4% for
overall post-operative infections and a rate of 3.4% for
post-operative SSI for the entire population examined.
Several risk factors for the development of a post-
operative infection were identified in our study. Ruptured
membranes, greater ASA score, having 6 or more vaginal
exams performed prior to the cesarean, blood loss of
greater than 500 ml during the operation and inadequate
prenatal follow-up were the most important ones. Our
findings concur with published literature on the subject
[29,31]. Regarding prenatal follow-up it is possible that
women with regular exams had conditions such as bac-
terial vaginosis that are predisposing factors for ruptured
membranes, premature labor and post-partum infection.
Of interest is the fact that previous research has identi-
fied an increased number of vaginal examinations and
increased length of internal monitoring as risk factors for
an enterococcus associated post-cesarean endometritis
[21]. We were not able to explain the finding of regional
anesthesia correlating with a higher risk for an SSI and
this finding needs to be further explored. Physicians
should identify those patients at highest risk for deve-
loping postoperative infections and maintain a close
follow-up for the weeks following the cesarean delivery.
If symptoms and signs of infection develop appropriate
diagnostic testing should be performed and every effort
made to identify an offending pathogen. Then appropri-
ate antimicrobial therapy will be prescribed according to
susceptibility testing. Gram negative flora predominated
in the infections observed in our cohort.
Limitations of our study include the lack of quantita-
tive microbiological data from women prior to the
Table 2 Variables studied in univariate analysis and their association with the development of any postoperative
infection (n = 13) and with development of post-operative SSI (n = 10)
Variable Post-op. Infection
n = 13 (7.4)
No Infection
n = 163 (92.6)
P Post-op. SSI
n = 10 (5.7)
No SSI
n = 166 (94.3)
P
Age, median (IQR) 27 (24-32) 28 (24-32) 1 28 (23-32) 28 (24-32) 1
Multiparity, n (%) 7 (53.8) 91 (55.8) 1 6 (60) 92 (55.4)
BMI >25 kg/m
2, n (%) 13 (100) 124 (76.1) 0.08 10 (100) 127 (76.5) 0.12
BMI ≥ 30 kg/m
2, n (%) 7 (53.8) 69 (42.3) 0.6 5 (5) 71 (42.8) 0.7
Diabetes mellitus, n (%) 0 (0) 7 (4.3) 1 0 (0) 7 (4.2) 1
Hypertension/other CVD, n (%) 0 (0) 36 (22.1) 0.07 0 (0) 36 (21.7) 0.2
Chronic respiratory disease, n (%) 0 (0) 1 (0.6) 0.9 0 (0) 1 (0.6) 1
Corticosteroid use, n (%) 0 (0) 2 (1.2) 1 0 (0) 2 (1.2) 1
Creatinine in mg/dL, median (IQR) 0.6 (0.5-0.85) 0.6 (0.5-0.7) 0.2 0.7 (0.5-0.8) 0.6 (0.5-0.7) 0.2
ASA ≥ 2, n (%) 7 (53.8) 52 (31.9) 0.1 5 (50) 54 (32.5) 0.3
Regular prenatal f/u, n (%) 11 (84.6) 156 (96.9) 0.09 8 (80) 159 (97) 0.05*
Vaginal examinations >1, n (%) 9 (69.2) 87 (53.4) 0.4 8 (80) 88 (53) 0.11
Vaginal examinations ≥ 6, n (%) 6 (46.2) 17 (10.4) 0.002* 5 (50) 18 (10.8) 0.004*
Ruptured membranes, n (%) 7 (53.8) 47 (28.8) 0.1 6 (60) 48 (28.9) 0.07
Ruptured membranes ≥ 6 hours, n (%) 2 (15.4) 7 (4.3) 0.1 2 (20) 7 (4.2) 0.08
Non-elective cesarean, n (%) 9 (69.2) 78 (47.9) 0.2 8 (80) 79 (47.6) 0.056
Type of anesthesia (general vs. regional), n of general (%) 5 (38.5) 105 (64.4) 0.08 2 (20) 108 (65.1) 0.006*
Duration of surgery >60 minutes, n (%) 10 (76.9) 101 (62) 0.4 7 (70) 104 (62.7) 0.7
Blood loss >500 ml, n (%) 10 (76.9) 64 (39.3) 0.016* 8 (80) 66 (39.8) 0.018*
Duration of hospitalization in days, median (IQR) 5 (4-8) 4 (4-4) <0.001* 5 (4-8) 4 (4-4) <0.001*
*: Significant associations p < 0.05. ASA: American society of Anesthesiologists score, BMI: Body mass index, CVD: Cardiovascular disease, Post-op: postoperative,
IQR: Interquartile range
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for qualitative data in cases of infection). This knowl-
edge would have allowed a much better understanding
of the role of the pathogen (and the prescribed antimi-
crobial prophylaxis regimen) in cesarean deliveries. For
example, presence of a microorganism in the genital
tract besides infection can also be found in instances of
colonization creating difficulty in clarifying the exact
pathogenetic role in instances of infection. The mono-
microbial nature of the culture results in all cases of
infection in our study, may have limited such a bias.
Furthermore, we had a significant number of emergency
procedures due to the nature of our institution which is
a tertiary care center with several referrals from subur-
ban and regional hospitals. This may have created a
selection bias for patients at a higher risk for infection.
In fact over 30% of the population studied had a high
ASA score. Another limitation is that the physician
assessing outcomes was not blinded to the group assign-
ments due to technical reasons and his participation as
an assistant in the vast majority of the operations
performed. Since the indicators of infection can be sub-
jective it is possible that the observations may have been
influenced by knowledge of the treatment group. How-
ever, accurate recording of several variables relating to
the operation per se was achieved due to this fact.
A third limitation is that we could not account for any
residual confounding in our risk factor associations.
A final limitation is the fact that the prophylaxis regi-
men was administered right after the time the umbilical
cord was clamped according to standard obstetrical
practice. However, a very recent position statement was
published by The American College of Obstetricians
and Gynecologists supporting a change in the current
practice and recommending that the prophylaxis should
be given 1 hour prior to the operation. Since our study
was performed in the past we could not adhere to this
guideline which will be implemented in the near future.
Conclusions
In conclusion, we report for the first time in the litera-
ture a randomized comparison of ampicillin-sulbactam
Patients who underwent 
Cesarean delivery
n = 176
Group A
(Cefuroxime)
n = 85 (48.3%)
High risk patients
n = 27 (31.8%)
SSI
n = 2
Low risk patients
n = 58 (68.2%)
SSI
n = 2
Enterococcal SSI
n = 1 
Group B
(Ampicillin/Sulbactam)
n = 91 (51.7%)
High risk patients
n = 32 (35.2%)
SSI
n = 3
Low risk patients
n = 59 (64.8%)
SSI
n = 3
Figure 2 A schematic diagram of the study according to prophylaxis group, operative risk (high versus low), type of surgery (elective,
emergency cesarean delivery) and development of Surgical Site Infection (SSI).
Ziogos et al. BMC Infectious Diseases 2010, 10:341
http://www.biomedcentral.com/1471-2334/10/341
Page 7 of 8v s .c e f u r o x i m ea ss i n g l ed o s ep r o p h y l a x i si nc e s a r e a n
delivery. Our study demonstrated equal efficacy of the
two regimens regarding prevention of postoperative
infections after cesarean delivery. Both antibiotics were
safe and well tolerated with no unusual or unexpected
events.
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